General Information


DRACP ID  DRACP01179

Peptide Name   Ⅰ

Sequence  XPAXXFXPAXXLXXLXXLX

Sequence Length  19

UniProt ID  Not available

PubChem CID  Not available

Origin  Peptaibols

Type  Native peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
HCT 8 Colon adenocarcinoma Carcinoma IC50>10 μM MTT assay 3-5 days Patent
BEL-7402 Human papillomavirus-related endocervical adenocarcinoma Carcinoma IC50=1.98 μM MTT assay 3-5 days Patent
BGC-823 Human papillomavirus-related endocervical adenocarcinoma Carcinoma IC50=2.11 μM MTT assay 3-5 days Patent
A549 Lung adenocarcinoma Carcinoma IC50=2.30 μM MTT assay 3-5 days Patent
A2780 Ovarian endometrioid adenocarcinoma; Endometrioid carcinoma of ovary Carcinoma IC50>10 μM MTT assay 3-5 days Patent

Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Acetylation

C-terminal Modification  Aminoethanol

Other Modification  X(1/4/5/16/17)=Aib=1-amino-isobutyric acid; X(7/13)=Iva=Isovaline; X(10)=AHMA=3-amino-2-hydroxy-3-methylbutanoic acid; X(11/14/19)(β)A=β-Alanine

Chiral  L



Physicochemical Information


Formula  C43H46N8O-2

Absent amino acids  CDEGHIKMNQRSTVWY

Common amino acids  X

Mass  217413

Pl  6.11

Basic residues  0

Acidic residues  0

Hydrophobic residues  6

Net charge  0

Boman Index  2136

Hydrophobicity  76.84

Aliphatic Index  72.11

Half Life 
  /

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  0

Amino acid distribution



Literature Information


Literature 1

Pubmed ID Not available

Title  Not available

Doi Not available

Year  Not available

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.